We detected an increase in the phosphorylated form of eIF2α and in the cleaved caspase-3 fraction, indicating that the eIF2α signaling pathway was upregulated in these prostate tumor cells following targeted IL-27 gene delivery, leading to apoptosis induction. The gene discussed is CASP3; the disease is prostate neoplasm.